Prioritizing functional goals as we rebuild the kidney

Benjamin D. Humphreys; Mark A. Knepper

doi:10.1681/ASN.2019101051

Prioritizing functional goals as we rebuild the kidney

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	2287-2288
Number of pages	2
Journal	Journal of the American Society of Nephrology
Volume	30
Issue number	12
DOIs	https://doi.org/10.1681/ASN.2019101051
State	Published - 2019

Access to Document

10.1681/ASN.2019101051

Cite this

@article{df8bb67bce364f03b0460d76e925661a,

title = "Prioritizing functional goals as we rebuild the kidney",

author = "Humphreys, {Benjamin D.} and Knepper, {Mark A.}",

note = "Funding Information: Dr. Humphreys is a member of the National Institutes of Health–funded ReBuilding a Kidney consortium (DK107374) and reports personal fees from Merck, personal fees from Janssen, personal fees from Medimmune, personal fees from Roche, personal fees from Celgene, personal fees from Chinook Therapeutics, personal fees from Genentech, grants from Chinook Therapeutics, grants from Janssen, and other from Chinook Therapeutics outside the submitted work. Dr. Knepper has nothing to disclose. Funding Information: Dr. Knepper is funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute (projects ZIA-HL001285 and ZIA-HL006129, MAK).",

year = "2019",

doi = "10.1681/ASN.2019101051",

language = "English",

volume = "30",

pages = "2287--2288",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

number = "12",

}

TY - JOUR

T1 - Prioritizing functional goals as we rebuild the kidney

AU - Humphreys, Benjamin D.

AU - Knepper, Mark A.

N1 - Funding Information: Dr. Humphreys is a member of the National Institutes of Health–funded ReBuilding a Kidney consortium (DK107374) and reports personal fees from Merck, personal fees from Janssen, personal fees from Medimmune, personal fees from Roche, personal fees from Celgene, personal fees from Chinook Therapeutics, personal fees from Genentech, grants from Chinook Therapeutics, grants from Janssen, and other from Chinook Therapeutics outside the submitted work. Dr. Knepper has nothing to disclose. Funding Information: Dr. Knepper is funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute (projects ZIA-HL001285 and ZIA-HL006129, MAK).

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85075813287&partnerID=8YFLogxK

U2 - 10.1681/ASN.2019101051

DO - 10.1681/ASN.2019101051

M3 - Review article

C2 - 31676726

AN - SCOPUS:85075813287

SN - 1046-6673

VL - 30

SP - 2287

EP - 2288

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 12

ER -

Prioritizing functional goals as we rebuild the kidney

Access to Document

Other files and links

Cite this